查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402596

止血劑和組織密封劑市場：依產品類型、應用、最終用戶、地區

Hemostasis and Tissue Sealing Agents Market, By Product Type, By Application, By End User, and By Region
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，全球止血劑和組織封閉劑市場規模為33.9億美元，2023年至2030年複合年成長率為5.6%，預計到2030年將達到49.5億美元。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 33.9億美元
實際資料 2018-2021 預測期 2023-2030
預測期複合年成長率 5.60% 2030年市場規模預測 49.5億美元
圖 1. 止血劑和組織封閉劑的全球市場佔有率(%)（依地區），2023 年
止血與組織封閉劑市場-IMG1

止血劑和組織密封劑在手術中發揮重要作用，使外科醫生能夠控制出血並密封組織。這些藥物的作用是在切口或傷口上形成保護層並促進身體的自然凝血過程。常用的止血和組織封閉產品包括封閉劑、黏劑、纖維蛋白貼片、膠原蛋白溶液和可吸收凝膠。由於心血管外科、骨科、整形外科血管外科和普通外科等各個外科領域對更有效的出血控制解決方案的需求不斷增加，全球止血和組織封閉劑市場正在成長。

市場動態：

刺激止血和組織密封劑市場的一些主要驅動因素包括全球外科手術的激增、對微創手術的偏好增加、新興經濟體醫療保健支出的增加以及導致產品組合改進的技術進步。 然而，由於安全問題導致的產品召回、嚴格的監管標準以及來自主要仿製葯製造商的價格壓力等因素是主要挑戰。 從好的方面來說，研發正在進行中，以開發具有卓越功效的下一代止血材料和密封劑，為市場參與者開闢新的途徑。 組織粘合劑在創傷修復中的應用越來越多，也為止血和組織密封劑市場的增長創造了有吸引力的機會。

本研究的主要特點

  • 該研究報告對全球止血劑和組織封閉劑市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模和復合年成長率。
  • 本報告揭示了各個區隔市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
  • 本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 本報告根據以下參數（例如公司亮點、產品系列、主要亮點、績效和策略）介紹了全球止血劑和組織密封劑市場的主要企業。
  • 本研究涵蓋的主要企業包括 Ethicon（強生子公司）、Baxter International、CryoLife、B. Braun Melsungen AG、Covidien（現為 Medtronic 的一部分）、Integra LifeSciences、輝瑞、BD、Teleflex 和 Arch Therapeutics。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球止血劑和組織密封劑市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球止血劑和組織密封劑市場的各種策略矩陣來促進他們的決策。

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章止血劑和組織封閉劑市場－冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章止血劑和組織封閉劑市場，依產品類型，2018-2030

  • 局部止血劑和黏劑
  • 組織密封劑

第6章止血劑與組織封閉劑市場，依應用分類，2018-2030

  • 心血管外科
  • 整形外科
  • 一般外科
  • 神經外科
  • 其他

第 7 章止血劑和組織封閉劑市場，依最終用戶分類，2018-2030 年

  • 醫院
  • 門診手術中心
  • 居家照護環境

第8章止血劑和組織封閉劑市場，依地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • Ethicon（a subsidiary of Johnson & Johnson）
  • Baxter International
  • CryoLife
  • B.Braun Melsungen AG
  • Covidien（now part of Medtronic）
  • Integra LifeSciences
  • Pfizer Inc.
  • BD
  • Teleflex
  • Arch Therapeutics

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI1567

The global hemostasis and tissue sealing agents market size is valued at US$ 3.39 Billion in 2023 and is expected to reach US$ 4.95 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.6% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.39 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.60% 2030 Value Projection: US$ 4.95 Bn
Figure 1. Global Hemostasis And Tissue Sealing Agents Market Share (%), By Region, 2023
Hemostasis and Tissue Sealing Agents Market - IMG1

Hemostasis and tissue sealing agents play a vital role in surgical procedures by enabling surgeons to control bleeding and seal tissues. They work by forming a protective layer over incisions and wounds to accelerate the body's natural clotting process. Some commonly used hemostasis and tissue sealing products include sealants, glues, fibrin patches, collagen-based solutions, and absorbable gels. The global hemostasis and tissue sealing agents market has been growing in response to the rising need for more effective hemorrhage management solutions across various surgical specialties like cardiovascular, orthopedic, neurovascular, and general surgeries.

Market Dynamics:

The key drivers fueling the hemostasis and tissue sealing agents market include rapid growth in surgical procedures globally, increasing preference for minimally invasive surgeries, rising healthcare spending in emerging nations, and technological advancements leading to improved product portfolios. However, factors such as product recalls owing to safety concerns, stringent regulatory norms, and price pressures from large generic manufacturers pose significant challenges. On the positive side, ongoing research and development towards developing next-gen hemostats and sealants with superior efficacy is opening new avenues for market players. Growing applications of tissue adhesives in traumatic injury repair also present attractive opportunities for growth of hemostasis and tissue sealing agents market.

Key Features of the Study:

  • This report provides an in-depth analysis of the global hemostasis and tissue sealing agents market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hemostasis and tissue sealing agents market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Ethicon (a subsidiary of Johnson & Johnson), Baxter International, CryoLife, B. Braun Melsungen AG, Covidien (now part of Medtronic), Integra LifeSciences, Pfizer, BD, Teleflex and Arch Therapeutics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global hemostasis and tissue sealing agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemostasis and tissue sealing agents market

Detailed Segmentation:

  • By Product Type:
    • Topical Hemostats & Adhesives
    • Tissue Sealing Agents
  • By Application:
    • Cardiovascular Surgery
    • Orthopedic Surgery
    • General Surgery
    • Neurosurgery
    • Others
  • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Home Care Settings
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Ethicon (a subsidiary of Johnson & Johnson)
    • Baxter International
    • CryoLife
    • Braun Melsungen AG
    • Covidien (now part of Medtronic)
    • Integra LifeSciences
    • Pfizer
    • BD
    • Teleflex
    • Arch Therapeutics

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Hemostasis and Tissue Sealing Agents Market , By Product Type
    • Global Hemostasis and Tissue Sealing Agents Market , By Application
    • Global Hemostasis and Tissue Sealing Agents Market , By End User
    • Global Hemostasis and Tissue Sealing Agents Market , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Hemostasis and Tissue Sealing Agents Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Hemostasis and Tissue Sealing Agents Market, By Product Type, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Topical Hemostats & Adhesives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Tissue Sealing Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Hemostasis and Tissue Sealing Agents Market, By Application, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Cardiovascular Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Orthopedic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • General Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Neurosurgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Hemostasis and Tissue Sealing Agents Market, By End User, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Hemostasis and Tissue Sealing Agents Market, By Region, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Ethicon (a subsidiary of Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Baxter International
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CryoLife
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • B.Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covidien (now part of Medtronic)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Integra LifeSciences
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teleflex
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Arch Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

  • Research Methodology
  • About us